Let's hope that people have the common sense to distinguish between one thing and another -
Dendreon being hammered because of issues that have, maybe, perhaps, SOME potential future commonality with Cvac's passage to market;
and Dendreon being hammered because of this investigation, which has nothing at all to do with the drugs but rather the management.
Let's hope.
where to tomorrow, page-22
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.5¢ | $694.0K | 2.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22530 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 176372 | 4 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |